ENZO BIOCHEM INC Quarterly Research and Development Expense in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
Summary
Enzo Biochem Inc quarterly/annual Research and Development Expense history and growth rate from Q3 2010 to Q3 2024.
  • Enzo Biochem Inc Research and Development Expense for the quarter ending October 31, 2024 was $562K, a 33.8% decline year-over-year.
  • Enzo Biochem Inc Research and Development Expense for the twelve months ending October 31, 2024 was $2.36M, a 41.9% decline year-over-year.
  • Enzo Biochem Inc annual Research and Development Expense for 2024 was $2.64M, a 32.3% decline from 2023.
  • Enzo Biochem Inc annual Research and Development Expense for 2023 was $3.9M, a 60.1% increase from 2022.
  • Enzo Biochem Inc annual Research and Development Expense for 2022 was $2.44M, a 25% decline from 2021.
Research and Development Expense, Trailing 12 Months (USD)
Research and Development Expense, Quarterly (USD)
Research and Development Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.36M $562K -$287K -33.8% Aug 1, 2024 Oct 31, 2024 10-Q 2024-12-16
Q2 2024 $2.64M $608K -$588K -49.2% May 1, 2024 Jul 31, 2024 10-K 2024-10-29
Q1 2024 $3.23M $605K -$279K -31.6% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-13
Q4 2023 $3.51M $580K -$545K -48.4% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-13
Q3 2023 $4.05M $849K +$150K +21.5% Aug 1, 2023 Oct 31, 2023 10-Q 2024-12-16
Q2 2023 $3.9M $1.2M +$1.46M May 1, 2023 Jul 31, 2023 10-K 2024-10-29
Q1 2023 $2.45M $884K -$249K -22% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-13
Q4 2022 $2.7M $1.13M +$305K +37.2% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-13
Q3 2022 $2.39M $699K -$45K -6.05% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-15
Q2 2022 $2.44M -$259K -$1.12M -130% May 1, 2022 Jul 31, 2022 10-K 2023-11-03
Q1 2022 $3.56M $1.13M +$297K +35.5% Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-14
Q4 2021 $3.26M $820K +$14K +1.74% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-20
Q3 2021 $3.25M $744K -$2K -0.27% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-12
Q2 2021 $3.25M $864K -$302K -25.9% May 1, 2021 Jul 31, 2021 10-K 2022-10-14
Q1 2021 $3.55M $836K -$327K -28.1% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-09
Q4 2020 $3.88M $806K -$259K -24.3% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-14
Q3 2020 $4.14M $746K -$308K -29.2% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-15
Q2 2020 $4.45M $1.17M +$333K +40% May 1, 2020 Jul 31, 2020 10-K 2022-10-14
Q1 2020 $4.12M $1.16M +$382K +48.9% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-11
Q4 2019 $3.73M $1.07M +$232K +27.9% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-16
Q3 2019 $3.5M $1.05M +$326K +44.8% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-11
Q2 2019 $3.18M $833K -$19K -2.23% May 1, 2019 Jul 31, 2019 10-K 2021-10-12
Q1 2019 $3.19M $781K -$18K -2.25% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-09
Q4 2018 $3.21M $833K +$21K +2.59% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-06
Q3 2018 $3.19M $728K -$19K -2.54% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-10
Q2 2018 $3.21M $852K -$5K -0.58% May 1, 2018 Jul 31, 2018 10-K 2020-10-19
Q1 2018 $3.22M $799K +$33K +4.31% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-10
Q4 2017 $3.18M $812K +$329K +68.1% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-11
Q3 2017 $2.85M $747K -$75K -9.12% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-10
Q2 2017 $2.93M $857K -$57K -6.24% May 1, 2017 Jul 31, 2017 10-K 2019-10-15
Q1 2017 $2.99M $766K -$116K -13.2% Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-11
Q4 2016 $3.1M $483K -$378K -43.9% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-12
Q3 2016 $3.48M $822K -$45K -5.19% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-07
Q2 2016 $3.52M $914K -$2K -0.22% May 1, 2016 Jul 31, 2016 10-K 2018-10-15
Q1 2016 $3.53M $882K +$73K +9.02% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-08
Q4 2015 $3.45M $861K +$27K +3.24% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-13
Q3 2015 $3.43M $867K +$76K +9.61% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-08
Q2 2015 $3.35M $916K +$273K +42.5% May 1, 2015 Jul 31, 2015 10-K 2017-09-27
Q1 2015 $3.08M $809K -$40K -4.71% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-08
Q4 2014 $3.12M $834K +$2K +0.24% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-09
Q3 2014 $3.12M $791K -$26K -3.18% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-08
Q2 2014 $3.14M $643K -$278K -30.2% May 1, 2014 Jul 31, 2014 10-K 2016-10-13
Q1 2014 $3.42M $849K -$140K -14.2% Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-09
Q4 2013 $3.56M $832K -$136K -14.1% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-12
Q3 2013 $3.7M $817K -$194K -19.2% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-09
Q2 2013 $3.89M $921K -$456K -33.1% May 1, 2013 Jul 31, 2013 10-K 2015-10-13
Q1 2013 $4.35M $989K -$599K -37.7% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-09
Q4 2012 $4.94M $968K -$735K -43.2% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-11
Q3 2012 $5.68M $1.01M -$614K -37.8% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-10
Q2 2012 $6.29M $1.38M -$598K -30.3% May 1, 2012 Jul 31, 2012 10-K 2014-10-09
Q1 2012 $6.89M $1.59M -$465K -22.7% Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-10
Q4 2011 $7.36M $1.7M -$318K -15.7% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-12
Q3 2011 $7.67M $1.63M -$132K -7.51% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-10
Q2 2011 $7.81M $1.98M May 1, 2011 Jul 31, 2011 10-K 2013-10-15
Q1 2011 $2.05M Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-11
Q4 2010 $2.02M Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-12
Q3 2010 $1.76M Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.